First-in-class drug candidate selected for development

European commission grants leniolisib orphan drug designation

Investigational vaccine candidate was generally safe across all dose and age groups

Funding will be used to develop novel IgE antibodies to treat cancer

California CDMO plots ambitious expansion in Geneva in biologics manufacturing play kblankenship Wed, 10/21/2020 – 18:25

Updated Date: Wed, 14 Oct 2020 00:00:00 EDT

Updated Date: Wed, 14 Oct 2020 00:00:00 EDT

Updated Date: Wed, 14 Oct 2020 00:00:00 EDT

Updated Date: Wed, 14 Oct 2020 00:00:00 EDT

Updated Date: Wed, 14 Oct 2020 00:00:00 EDT